STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway

Signal Transduct Target Ther. 2022 Jul 8;7(1):209. doi: 10.1038/s41392-022-01050-7.

Ran Wang^{1

2}, Jianghong Cai¹, Keyuan Chen¹, Menglin Zhu¹, Zhaoyi Li¹, Hua Liu³, Tiantian Liu^{1

3}, Jianchun Mao⁴, Qian Ding¹, Yi Zhun Zhu^{5

6}

¹ State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
² School of Pharmacy, Minzu University of China, Beijing, 100081, China.
³ Department of Pharmacy, Aerospace Center Hospital, Beijing, 100049, China.
⁴ Department of Rheumatology, Longhua Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
⁵ State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China. yzzhu@must.edu.mo.
⁶ Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China. yzzhu@must.edu.mo.

No abstract available

Publication types